Rare diseases
Investigational molecules
Locations
VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
FranceDurvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer
FranceDoxycycline for Asymptomatic Anal LGV Infection in Patients with Asymptomatic Anal LGV Infection
FranceNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
FranceAsciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase
FranceJNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments
FranceTelisotuzumab Adizutecan for Locally Advanced or Metastatic Solid Tumors with MET Amplification in Patients 12 Years and Older
FranceLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
FranceEIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors
FrancePumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
FranceStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
FranceQTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
